Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand
Phytotherapy Research · 2023-04 · 37 (4) · 1227-1231
DOI: 10.1002/ptr.7699 ↗Kurz gefasst
Leserbrief in der Zeitschrift Phytotherapy Research, online erschienen am 28.11.2022. Verfasst von Alberto Boretti. Beteiligte Einrichtung: Johnsonville, Wellington, New Zealand. Hauptthemen laut MEDLINE: Quercetin, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Quercetin has a wide range of potential health benefits, working as a direct or indirect agent or an adjuvant following different principles. It may be used as a generally useful or exclusive supplement, but also specifically used to treat an acute or chronic condition. Quercetin may work as a cancer chemopreventive and chemotherapeutic agent, because this versatile substance, which owns antioxidant and anti‐inflammatory properties, may also kill cancer cells and also holds senolytic properties. While both the specific chemo‐preventive or chemotherapeutic uses as a drug need clinical trials, it may be used without any contraindication as a general chemo‐preventive supplement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johnsonville, Wellington, New Zealand.
ORCID-Profile: Alberto Boretti
Zitieren
APA
Boretti, A. (2023). Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand. Phytotherapy Research, 37(4), 1227-1231. https://doi.org/10.1002/ptr.7699
Vancouver
Boretti A. Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand. Phytotherapy Research. 2023;37(4):1227-1231. doi:10.1002/ptr.7699
BibTeX
@article{Boretti2023,
author = {Boretti, Alberto},
title = {Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {4},
pages = {1227--1231},
doi = {10.1002/ptr.7699}
}
EUVIMED